Geriatric emergency medication safety recommendations: Difference between revisions
No edit summary |
No edit summary |
||
| Line 81: | Line 81: | ||
|- | |- | ||
|[[Sulfonylureas]] | |[[Sulfonylureas]] | ||
*Examples: [[Glipizide]], [[glyburide]] | |||
| | | | ||
*[[Metformin]], long-acting [[insulin]] (e.g., [[glargine]]) | *[[Metformin]], long-acting [[insulin]] (e.g., [[glargine]]) | ||
Revision as of 23:10, 20 May 2026
High-Risk Medications to Avoid for Geriatric Patients at ED Discharge[1]
| High-Risk Therapeutic Class (AVOID) | Alternative Options (Preferred) | Valid Exceptions^ (Use with Caution) |
|---|---|---|
Barbiturates
|
|
|
| Benzodiazepines |
|
|
First-generation antihistamines
|
|
|
| Metoclopramide |
|
|
First-generation antipsychotics
|
|
|
Nonbenzodiazepines (Z-drugs)
|
|
|
Skeletal muscle relaxants
|
|
|
| Sulfonylureas |
^Indications for use where high-risk medication benefit may outweigh risks.
See Also
- ↑ Skains, et al. Geriatric Emergency Medication Safety Recommendations (GEMS-Rx). Annals of Emergency Medicine. September 2024. 84(3):274-284. https://doi.org/10.1016/j.annemergmed.2024.01.033
